June 23, 2020 / 5:11 AM / 13 days ago

BRIEF-Santhera Says UK's MHRA Renews EAMS Opinion For Idebenone

June 23 (Reuters) - SANTHERA PHARMACEUTICALS HOLDING AG :

* UK’S MHRA RENEWS EAMS SCIENTIFIC OPINION FOR SANTHERA’S IDEBENONE IN DUCHENNE MUSCULAR DYSTROPHY

* EXPECTS AN OPINION BY COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) IN Q4 2020 Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below